Dr. Brummitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2801 W Kinnickinnic River Pkwy
Suite 436
Milwaukee, WI 53215Phone+1 414-649-3577- Is this information wrong?
Summary
- Dr. Charles Brummitt is an infectious disease specialist in Milwaukee, WI at Aurora St. Luke's Medical Center. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 35 years. He is experienced in hiv/aids, epidemiology, and antibiotic stewardship.
Education & Training
- University of MinnesotaFellowship, Infectious Disease, 1985 - 1988
- University of MinnesotaResidency, Internal Medicine, 1983 - 1985
- University of MinnesotaInternship, Internal Medicine, 1982 - 1983
- University of Wisconsin School of Medicine & Public HealthClass of 1982
- University of WisconsinB.S, 1978
Certifications & Licensure
- WI State Medical License 1986 - 2023
- MN State Medical License 1983 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Top Doctor
- Best Doctors in America
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsImpact of a Systematic Pharmacist-Initiated Antibiotic Time-Out Intervention for Hospitalized Adults.Calley M Paulson, Jillian F Handley, Thomas J Dilworth, Dan Persells, Rachael Y Prusi, Charles F Brummitt, Katherine M Torres, Lee P Skrupky> ;Journal of Pharmacy Practice. 2020 Dec 23
- 3 citationsReduction in ambulatory visits for acute, uncomplicated bronchitis: an unintended but welcome result of the coronavirus disease 2019 (COVID-19) pandemic.Thomas J Dilworth, Charles F Brummitt> ;Infection Control and Hospital Epidemiology. 2021 Oct 1
- 4 citationsComparison of Clinical Outcomes among Intensive Care Unit Patients Receiving One or Two Grams of Ceftriaxone Daily.Andrew Ackerman, Nathaniel R. Zook, Jeremy F. Siegrist, Charles F Brummitt, Margaret Cook, Thomas J Dilworth> ;Antimicrobial Agents and Chemotherapy. 2020 May 21
- Join now to see all
Journal Articles
- Treatment with Lamivudine, Zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter.Eron, J.J., Benoit, S. L., Jemsek, J., MacArthur, R.D., Santana, J., Quinn, J.B., Kuritzkes, D.R., Fallon, M.A., Rubin, M, New Engl J Med 333:1662-69
- Lamivudine plus Zidovudine compared with Zalcitabine plus Zidovudine.Bartlett, J.A. , Benoit, S.L., Johnson, V.A., Quinn, J.B., Sepulveda, G.E., Ehmann, W.C., Tsoukas, C., Fallon, M.A., Self, P.L., Rubin, M, Ann Intern Med 125:161-172
- Fat not Fiction.Brummitt, C. F, New Scientist 182 (2249):30
Books/Book Chapters
Abstracts/Posters
- Large common-source outbreak of adenovirus type 3 among hospital personnel.Van Drunen, M., Juni, B.A., Brummitt, C.F., Cameron, S. B., Cherrington, J., Edelman, C., and Katzenstein, D, 86th Annual Meeting, American Society for Microbiology
- Opioid-mediated suppression of human mononuclear cell interferon-production.Brummitt, C.F., Sharp, B., Gekker, G., Keane, W.F., and Peterson, P.K, Clin Res 35:469A, Federation for Clinical Research
- Beta-endorphin inhibits interleukin-1 release by cultured peripheral blood mononuclear cells.Brummitt, C.F., Sharp, B., Gekker, G., Keane, W.F., and Peterson, P.K, First International Workshop on Monokines and Non-lymphocytic Cytokines
- Join now to see all
Press Mentions
- How to Avoid Misusing AntibioticsAugust 19th, 2019
Hospital Affiliations
- Aurora St. Luke's Medical CenterMilwaukee, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: